Category Archives: Best Stocks

Kate and William can afford 3 kids. Many Brits cannot

For the Duke and Duchess of Cambridge, having three kids won’t break the bank. For many other Millennial Brits, a family of that size just isn’t an option.

Catherine, Duchess of Cambridge, gave birth to the couple’s third child, a son, on Monday.

Raising one child in the United Kingdom to the age of 21 costs about 拢232,000 ($323,000), according to the Centre for Economics and Business Research (CEBR). In London, that rises to 拢254,000 ($354,000).

That means a London-based family with three children is looking at a total cost of more than $1 million, and that doesn’t include private schools or university fees, which together can easily add another $200,000 per child.

To put this in perspective, the median UK income for a working household is just 拢29,300 ($40,100) per year, after income tax deductions, according to the UK Office for National Statistics.

in story cost raising child uk london chart 3

Earning power isn’t a problem for Kate and Prince William. They receive millions from Prince Charles to cover the cost of their official duties, own a country mansion, and enjoy a London residence Kensington Palace rent free.

The average Londoner, by contrast, will have to pay 拢472,000 ($658,000) to buy a home.

Little wonder then that British women are having far fewer children than past generations.

Here are a few reasons why:

Higher costs are putting couples off

National statistics show the average British woman has just 1.8 children each. In the 1960s, during the so-called Baby Boom, it was close to three children each.

Rising female education has been associated with lower birth rates. But cold, hard financial considerations seem to have played into many couples’ decisions too.

CEBR research from 2014 found that 21% of parents said they were delaying having another child due to the rising cost of raising a family.

Pay squeeze and expensive housing

Millennial parents those born in the 1980s and 1990s are facing particular challenges, including slower wage growth, which could influence their decisions on having children.

Research from the Resolution Foundation shows previous British generations earned significantly more than their predecessors after calculating for inflation. But this trend doesn’t hold for Millennials, who are earning less than Generation X those born between 1966 and 1980 and have seen their wages squeezed following the Great Recession.

“This stalling of generational pay progress is unprecedented,” Resolution Foundation researchers said in a recent report.

The rising cost of housing is adding to the pressure.

“Millennials today are spending more of their income on housing than previous generations did at the same age, but critically get less for their money when it comes to security and quality of life,” the report noted.

prince william price george princess charlotte The Duke of Cambridge led his two children to meet their new brother in the hospital on April 23.

Less state support for large families

Recent changes in government policy also seem to be discouraging people from having three or more children, according to Donald Hirsch, director of the Centre for Research in Social Policy at Loughborough University.

Since 2017, government credits to poorer families with three or more children have been trimmed.

“This rule can be interpreted as saying that society disapproves of you having more than two children if you are poor,” said Hirsch.

People may think the cost of raising a second or third child is cheaper than the first, but that’s not necessarily the case.

“There are some economies of scale, but there are lots of extra costs with having a third child,” said Hirsch. “You may have to buy a new car … You may need a larger home.”

Best Tech Stocks To Watch Right Now

The year 2018 has gotten off to a great start. Earnings season is delivering some serious winners for investors, and companies are generally raising guidance on the heels of tax reform, overseas capital repatriation, immediate expensing, accelerated earnings and economic growth. With the S&P 500 rising over 19% in 2017, it was last seen up over 7% so far in 2018, and that’s with the first month not even fully over.

Investors know that it’s a raging bull market and they need to own some of the best-performing stocks. The problem that is surfacing is that some companies have seen their stocks rise to the point that they may now be priced for perfection. And if a company hasn’t yet reported earnings, that means that it has to beat earnings expectations, talk up their guidance and talk about tax reform and the broader economic climate are set to benefit them in the years ahead.

Alphabet Inc. (NASDAQ: GOOGL) is one such company that will have to have a great quarterly earnings report and positive conference call. It was recently featured (along with Netflix, which did deliver big) as one of 10 tech giants getting the most upgrades ahead of earnings, which we deemed as Wall Street saying “You better please us, or else …”

Best Tech Stocks To Watch Right Now: RepliCel Life Sciences Inc. (REPCF)

Advisors’ Opinion:

  • [By Sara Cornell]

    RepliCel Life Sciences Inc. (OTCBB: REPCF) (TSX: RP.V) – could be changing the way we treat baldness and hair loss in the future.

    A clinical-stage regenerative medicine company, RepliCel is developing a unique biologic product that harnesses a patient’s own cells to treat pattern baldness and thinning hair, as well as products for aging and sun-damaged skin, and chronic tendon degeneration. The company recently announced the successful completion of its first-in-human clinical study of autologous cell therapy for the treatment of Androgenetic Alopecia, commonly known as pattern baldness.

Best Tech Stocks To Watch Right Now: J & J Snack Foods Corp.(JJSF)

Advisors’ Opinion:

  • [By Monica Gerson]

    J & J Snack Foods Corp (NASDAQ: JJSF) is estimated to post its quarterly earnings at $0.78 per share on revenue of $231.58 million.

    Nabors Industries Ltd. (NYSE: NBR) is expected to post a quarterly loss at $0.33 per share on revenue of $630.85 million.

Best Tech Stocks To Watch Right Now: McDermott International, Inc.(MDR)

Advisors’ Opinion:

  • [By Paul Ausick]

    McDermott International Inc. (NYSE: MDR) traded down about 7.9% Friday to post a new 52-week low of $5.38 after closing Thursday at $5.84. The stock’s 52-week high is $9.07. Volume was more than double the daily average of around 7.5 million shares. The company said this morning that remains committed to i’s proposed merger with Chicago Bridge & Iron, irrespective of negative sentiment from investment firm Hotchkis & Wiley.

  • [By Lisa Levin] Gainers
    McDermott International, Inc. (NYSE: MDR) rose 19 percent to $7.20 in pre-market trading. Subsea 7 S.A. confirmed a $7.00 per share proposal to acquire McDermott.
    Clarus Corporation (NASDAQ: CLAR) rose 18.5 percent to $8.00 in pre-market trading.
    Enbridge Inc. (NYSE: ENB) rose 9.3 percent to $34.09 in pre-market trading after falling 2.41 percent on Friday.
    Lannett Company, Inc. (NYSE: LCI) rose 8.4 percent to $18 in pre-market trading. Lannett named Maureen M. Cavanaugh as senior vice president and chief commercial operations officer.
    Navios Maritime Midstream Partners L.P. (NYSE: NAP) rose 7.1 percent to $4.55 in pre-market trading after gaining 11.26 percent on Friday.
    Corcept Therapeutics Incorporated (NASDAQ: CORT) rose 6.9 percent to $18.80 in pre-market trading after falling 3.19 percent on Friday.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) rose 5.7 percent to $2.40 in pre-market trading after falling 10.98 percent on Friday.
    Vectren Corporation (NYSE: VVC) shares rose 5.6 percent to $69.20 in pre-market trading. CenterPoint Energy, Inc. (NYSE: CNP) announced plans to acquire Vectren for $72 per share in cash
    Genprex, Inc. (NASDAQ: GNPX) shares rose 5.2 percent to $4.50 in pre-market trading.
    Atossa Genetics Inc. (NASDAQ: ATOS) rose 5.1 percent to $3.70 in pre-market trading after declining 19.35 percent on Friday.
    Sangamo Therapeutics, Inc. (NASDAQ: SGMO) shares rose 5 percent to $20 in pre-market trading.
    Magellan Midstream Partners, L.P. (NYSE: MMP) shares rose 5 percent to $68.41 in pre-market trading.
    Halozyme Therapeutics, Inc. (NASDAQ: HALO) shares rose 4.9 percent to $19.78 in the pre-market trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin]

    McDermott International, Inc. (NYSE: MDR) shares shot up 15 percent to $6.98 after the UK-based offshore oil service company Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron Company.

best way to invest money

October 13, 2016: Here are four stocks trading with relatively heavy volume among 80 equities making new 52-week lows in Thursday’s session. On the NYSE, decliners led advancers by 2 to 1 and on the Nasdaq decliners led advancers by more than 2 to 1.

Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) dropped 3.6% on Thursday to post a new 52-week low of $5.35 against a 52-week high of $10.58. Volume of about 28 million was about 6 times the daily average of around 4.8 million. The stock closed at $5.55 on Wednesday night. The Swedish network gear maker warned on revenues and earnings Wednesday morning.

Nokia Corp. (NYSE: NOK)) lost about 4.1% Thursday to post a new 52-week low of $4.88 after closing Wednesday at $5.09. The 52-week high is $7.63. Volume of around 21 million was about double the daily average of around 11 million shares traded. The stock was cut from Goldman’s Conviction Buy list this morning.

Bristol-Myers Squibb Inc. (NYSE: BMY) lost nearly 1.8% Thursday to post a new 52-week low of $49.12 after closing Wednesday at $50.01. The 52-week high is $77.12. Volume of around 12 million was about 10% below the daily average of about 13.5 million shares traded. Another stock removed from Goldman’s Conviction Buy list.

best way to invest money: Mead Johnson Nutrition Company(MJN)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    The group agreed to sell its food business to McCormick & Company Inc. (MKC)  last week for $4.2 billion. Reckitt said it would use the sale proceeds to reduce debt, which grew by $21 billion through a pair of financing transactions in March led by Bank of America Merrill Lynch, Deutsche Bank and HSBC in order to fund its $18 billion acquisition of infant nutrition group Mead Johnson (MJN) earlier this year.

  • [By Michael Flannelly]

    On Tuesday, JP Morgan analysts upgraded children’s nutrition company Mead Johnson Nutrition (MJN), as they believe the company’s top line growth should be valued more highly than the possible cost headwinds and further Chinese regulations.

    The analysts upgraded MJN from “Neutral” to “Overweight” and see shares reaching $88. This price target suggests a 16% upside to the stock’s Monday closing price of $76.11.

    Mead Johnson Nutrition shares were up 85 cents, or 1.12%, during morning trading on Tuesday. The stock is up 16.71% year-to-date.

best way to invest money: United Technologies Corporation(UTX)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    Here is the list of the Dow components, which are scheduled to report this week:

    1. 3M Co
    Company: 3M Co (NYSE: MMM). Date of Reporting: Tuesday, before the market open. EPS Estimate vs. Year-ago EPS: $2.54 versus $2.08. Revenue Estimate: $7.86 billion versus $7.66 billion. Stock Gain/Loss (year to date): 18.12 percent.
    2. Caterpillar
    Company: Caterpillar Inc. (NYSE: CAT). Date of Reporting: Tuesday, before the market open. EPS Estimate vs. Year-ago EPS: $1.25 versus $1.09. Revenue Estimate: $10.93 billion versus $10.94 billion. Stock Gain/Loss (year to date): 16.10 percent.
    3. McDonald’s
    Company: McDonald’s Corporation (NYSE: MCD). Date of Reporting: Tuesday, before the market open. EPS Estimate vs. Year-ago EPS: $1.62 versus $1.45. Revenue Estimate: $5.96 billion versus $6.26 billion. Stock Gain/Loss (year to date): 25.35 percent.
    4. United Technologies
    Company: United Technologies Corporation (NYSE: UTX) Date of Reporting: Tuesday, before the market open. EPS Estimate vs. Year-ago EPS: $1.78 versus $1.82. Revenue Estimate: $15.24 billion versus $14.87 billion. Stock Gain/Loss (year to date): 12.47 percent.

    See also: 3 Reasons Alcoa Is No Longer The Curtain-Raising Event Of Earnings Season

  • [By ]

    It’d be one thing if GE were cheap, but on many metrics, it’s not. Many investors at this point would rather pay for United Technologies Corporation (UTX)  , Honeywell International Inc. (HON)  or 3M Co (MMM)  — the last two of which are holdings in Jim Cramer’s Action Alerts PLUS Charitable Trust Portfolio.

  • [By Paul Ausick]

    United Technologies Corp. (NYSE: UTX) traded down 1.07% at $116.63. The stock’s 52-week range is $106.21 to $124.79. Volume was about 25% below the daily average of around 3.6 million shares. The company had no specific news.

  • [By Lisa Levin]

    United Technologies Corporation (NYSE: UTX) will acquire Rockwell Collins, Inc. (NYSE: COL) in a deal worth $30 billion , forging an aerospace behemoth producing virtually all types of avionics systems for commercial and defense aircraft.

  • [By Chris Lange]

    On Wednesday, United Technologies Corp. (NYSE: UTX) also is scheduled to reveal its fourth-quarter results. The consensus estimates are $1.56 in EPS and $15.36 billion in revenue. Shares were trading at $135.90 as the week came to a close. The consensus price target is $139.63. The 52-week trading range is $106.85 to $137.73.

  • [By Paul Ausick]

    The DJIA stock posting the largest daily percentage gain ahead of the close Monday was United Technologies Corp. (NYSE: UTX) traded up 2.08% at $110.78. The stock’s 52-week range is $83.39 to $111.69. Volume was about 10% below the daily average of around 3.6 million shares. The company’s stock was lifted from Neutral to Outperform by Credit Suisse analysts on Monday.

best way to invest money: Sotheby's(BID)

Advisors’ Opinion:

  • [By Travis Hoium]

    Shares of auction house Sotheby’s (NYSE:BID) jumped 13.6% in February, according to data provided by S&P Global Market Intelligence, after a fourth-quarter earnings report wowed investors. And given the company’s momentum, 2017 could be a great year for the company.

  • [By Lisa Levin]

    Sothebys (NYSE: BID) reported better-than-expected results for its fourth quarter on Monday.

    Sothebys posted quarterly adjusted earnings of $1.35 per share on revenue of $308.69 million. Analysts were expecting earnings of $1.17 per share on revenue of $277.28 million.

  • [By Marshall Hargrave]

    Now Loeb's looking to put that capital to work in other markets, with the art market being a perfect candidate. Loeb and his Third Point hedge fund have started their latest activist campaign with leading auction house Sotheby's (NYSE: BID). Loeb joins fellow activist investor Marcato Capital in the stock.

best way to invest money: Midatech Pharma PLC(MTP)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    But before we show you our pick, here are the top 10 penny stocks to watch this week…

    Penny Stocks Current Share Price (as of Jan. 5) Jan. 2-5 Gain (as of Jan. 5)
    My Size Inc. (Nasdaq: MYSZ) $1.66 152.28%
    Cytori Therapeutics Inc. (Nasdaq: CYTX) $0.47 89.52%
    DelMar Pharmaceuticals Inc. (Nasdaq: DMPI) $1.675 58.02%
    CAS Medical Systems Inc. (Nasdaq: CASM) $1.09 55.71%
    China HGS Real Estate Inc. (Nasdaq: HGSH) $1.83 47.58%
    Aethlon Medical Inc. (Nasdaq: AEMD) $1.56 43.12%
    Midatech Pharma Plc. (Nasdaq: MTP) $1.23 43.01%
    Comstock Holding Cos. Inc. (Nasdaq: CHCI) $1.87 36.5%
    Cenveo Inc. (Nasdaq: CVO) $1.20 31.82%
    EV Energy Partners LP (Nasdaq: EVEP) $0.6844 31.62%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…

Top 10 Undervalued Stocks To Own For 2019

We continue to believe that financial stocks are quite undervalued as well. During the quarter we made a new investment in Ally Financial (NYSE:ALLY). Ally was founded nearly a century ago as General Motors Acceptance Corporation. Its purpose then was to provide financing to GM dealers and retail customers. Today, Ally is no longer owned by GM. It serves a wide variety of dealers (including Ford, Chrysler and Toyota), and it is carefully building a consumer franchise. In our view, investors are myopically concerned that the auto business is at a cyclical peak. U.S. auto sales are near record levels, and credit losses are below long-term averages. Some believe Ally’s earnings have nowhere to go but down. We believe cyclical pressures will be more than offset by continued internal improvements, such as funding cost reductions (low-cost online deposits grew 19% in the third quarter of 2016) and improving the capital structure. With Ally’s stock trading at roughly 68% of tangible book value, we believe Ally is a compelling addition to the Oakmark Select Fund. We didn’t eliminate any positions during the quarter and exit 2016 with 20 investments in the portfolio.

From Bill Nygren (Trades, Portfolio)’s Oakmark Select Fund fourth quarter 2016 commentary.

Top 10 Undervalued Stocks To Own For 2019: Packaging Corporation of America(PKG)

Advisors’ Opinion:

  • [By Christopher Freeburn]

    Shares of Packaging Corp. (PKG) jumped almost 13% in pre-market trading on Monday after the company announced that it will purchase a rival containerboard-maker.

  • [By Ben Levisohn]

    Packaging Corp. of America(PKG) has jumped 6.3% to $57.99 after it said it would buy Boise (BZ) for $1.28 billion. Boise has gained 26% to $12.55.

  • [By Paul Ausick]

    Stocks on the move: Boise Inc. (NYSE: BZ) is up 26% at $12.55 following the companys acquisition by Packaging Corporation of America Inc. (NYSE: PKG) for $12.55 a share ($1.28 billion). Omeros Corp. (NASDAQ: OMER) is up 68.2% at $8.56 following an analyst upgrade. Northern Dynasty Minerals Ltd. (NYSEArca: NAK) is down 33.3% at $1.48 following an announcement from Anglo American plc that it was withdrawing from a massive copper mining project in Alaska.

Top 10 Undervalued Stocks To Own For 2019: Beazer Homes USA, Inc.(BZH)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market performed well on Tuesday, responding to steady improvement among many companies as earnings season kicked into high gear. Although political issues are likely to remain in the spotlight for some investors for the foreseeable future, many market participants are looking to economic and business issues in driving their investing decisions. Major market benchmarks finished the day with gains of 0.5% to 1%, but some stocks did much better. Among the best performers on the day were Allegheny Technologies (NYSE:ATI), II-VI (NASDAQ:IIVI), and Beazer Homes (NYSE:BZH). Below, we’ll look more closely at these stocks to tell you why they did so well.

Top 10 Undervalued Stocks To Own For 2019: Paylocity Holding Corporation(PCTY)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Box Inc underperforming potential mid cap peers Paycom Software Inc (NYSE: PAYC)andTriNet Group Inc (NYSE: TNET)plussmall cap peer Paylocity Holding Corp (NASDAQ: PCTY) whichall had IPOs around the same time:

  • [By Peter Graham]

    A long term performance chart shows shares of Box Inc underperforming potential mid cap peer Paycom Software Inc (NYSE: PAYC)and small cap peers Paylocity Holding Corp (NASDAQ: PCTY) and TriNet Group Inc (NYSE: TNET)whichall had their IPOs around the same time:

  • [By Peter Graham]

    A long term performance chart shows shares of Box Inc underperforming potential mid cap peer Paycom Software Inc (NYSE: PAYC)and small cap peers Paylocity Holding Corp (NASDAQ: PCTY) and TriNet Group Inc (NYSE: TNET)whichall had IPOs around the same time:

  • [By Peter Graham]

    A long term performance chart shows shares of Box Inc underperforming potential small cap peers such asPaycom Software Inc (NYSE: PAYC), Paylocity Holding Corp (NASDAQ: PCTY) and TriNet Group Inc (NYSE: TNET)which also debuted around the same time:

Top 10 Undervalued Stocks To Own For 2019: SCIENCE APPLICATIONS INTERNATIONAL CORPORATION(SAIC)

Advisors’ Opinion:

  • [By Monica Gerson]

    Science Applications International Corp (NYSE: SAIC) is estimated to report its quarterly earnings at $0.74 per share on revenue of $1.15 billion.

  • [By Monica Gerson]

    Wall Street expects Science Applications International Corp (NYSE: SAIC) to report its quarterly earnings at $0.74 per share on revenue of $1.15 billion. SAIC shares gained 0.96 percent to $57.87 in after-hours trading.

  • [By Lisa Levin]

    Gainers

    Pyxis Tankers Inc. (NYSE: PXS) rose 47.48 percent to $$5.56, after the company announced it has entered into a definitive securities purchase agreement with a group of investors, which will result in gross proceeds of $4.8 million.
    Sigma Designs Inc (NASDAQ: SIGM) rose 22.77 percent to $6.88. Silicon Laboratories (NASDAQ: SLAB) announced plans to buy Sigma Designs for $7.05 per share in cash.
    Steadymed Ltd (NASDAQ: STDY) rose 19.35 percent to $3.70, after the company reported that no clinical trials were required for Trevyent and that the FDA had agreed to the pathway for the drug candidate's NDA resubmission.
    Iteris, Inc. (NASDAQ: ITI) rose 15.73 percent to $7.06. Earlier in the week, Zacks Investment Research had upgraded the company from "Sell" to "Hold".
    Science Applications International Corp (NYSE: SAIC) rose 13.71 percent to $85.77 as the company reported better-than-expected earnings for its third quarter.
    Technical Communications Corporation (NASDAQ: TCCO) rose 12.41 percent to $6.07, after having risen sharply in pre-marketing trading.
    Radius Health, Inc. (NASDAQ: RDUS) rose 12.41 percent to $30.81 after the company provided an update on data from the Phase 1 005 clinical study of elacestrant in patients with estrogen receptor positive breast cancer during the 2017 San Antonio Breast Cancer Symposium.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 12.32 percent to $25.80 after the company reported its third quarter financial results.
    Prana Biotechnology Limited (NASDAQ: PRAN) rose 11.36 percent to $3.43, as the company announced a research collaboration with Takeda Pharmaceuticals to study the ability of movement disorders compound, PBT434 to slow or prevent neurodegeneration of the gastrointestinal system.
    Catalyst Biosciences, Inc. (NASDAQ: CBIO) rose 10.49 percent to $7.90 as the company announced the appointment of Arwa Shurrab and Jamie Ellen Siegel in its clinical hemophilia

Top 10 Undervalued Stocks To Own For 2019: NEW GOLD INC.(NGD)

Advisors’ Opinion:

  • [By Paul Ausick]

    New Gold Inc. (NYSEAMERICAN: NGD) dropped about 3.8% Thursday to post a new 52-week low of $2.28. Shares closed at $2.37 on Wednesday and the stock’s 52-week high is $4.25. Volume was about 15% below the daily average of around 5.9 million shares. The company had no specific news.

  • [By Dan Caplinger]

    The stock market lost ground on Monday, sending major market benchmarks lower by more than half a percentage point. The Dow lost its grip on the 20,000 mark in the wake of concerns about economic growth and new U.S. immigration policy, and some believe that the broader geopolitical climate could have a negative impact on global commerce that in turn could start affecting multinational corporations’ business prospects. In addition, bad news from some individual companies weighed on the markets, and Transocean (NYSE:RIG), Rite Aid (NYSE:RAD), and New Gold (NYSEMKT:NGD) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Paul Ausick]

    New Gold Inc. (NYSEAMERICAN: NGD) dropped about 2.9% Monday to post a new 52-week low of $2.35. Shares closed at $2.42 on Friday and the stock’s 52-week high is $4.25. Volume was about 10% below the daily average of around 5.8 million shares. The gold mining company had no news.

Top 10 Undervalued Stocks To Own For 2019: Vitality Biopharma (VBIO)

Advisors’ Opinion:

  • [By James E. Brumley]

    Investors who were looking to learn a little more about up-and-coming drug development company Vitality Biopharma Inc (OTCMKTS:VBIO) may want to mark December 8th on their calendar…. if they’re going to be in the Los Angeles area that day anyway. The company will be making a presentation that day, at the annual LD Micro Main Event. Interested and approved investors can attend the VBIO presentation by registering beforehand with LD Micro.

    Vitality Biopharma has found a way to make cannabinoid-based pharmaceuticals without the usual downside of cannabinoids. Namely, Vitality Biopharma’s version of cannabinoids are non-psychotropic, meaning larger, more effective dosing is possible without the ‘high’. It’s this little detail that takes cannabinoid medicine — already the most compelling frontier in the world of pharma — to the next level. There’s a reason some people think the cannabinoid market could be worth $20 billion by 2020.

    The idea was significantly advanced in early November. In eight of the nine states voters were asked about legalization of marijuana (for one reason or another), voters said yes….. four for recreational use, and four for medical use. In eight of those nine states, the measures passed. Marijuana is legal in more than half the United States now, and we’re en route to a decided majority in the foreseeable future.

    VBIO didn’t necessarily need a sweeping victory at the ballot box, but each time marijuana wins, it seems to advance the discussion of the power of cannabinoids as medicine.

    Investors will be able to learn more about Vitality Biopharma’s work in that arena on Thursday of this week. On that day — 8 AM PST / 11 AM EST — at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Robert Brooke, CEO of Vitality Biopharma, will be making a presentation as well as meeting with current and prospective investors.

    LD Micro was founded in 2006 with the sole purpose of being an independent resource in t

  • [By Jim Robertson]

    That’s why its worth pointing out that just yesterday, small cap cannabinoid prodrug pharmaceutical stock Vitality Biopharma, Inc. (OTCQB: VBIO) announced the appointment of Tracy Rockney, J.D. to the position of Senior Regulatory Advisor. In addition to being the Co-Founder & Chief Operating Officer of OneSource Regulatory, a regulatory consulting firm, Rockney was previously:

  • [By James E. Brumley]

    Are you an investor interested in learning more about Vitality Biopharma Inc (OTCMKTS:VBIO)? Or, are you looking to take your first look at VBIO? A SeeThruEquity research report posted in August not only has you covered, it underscores all of its hidden bullishness. The report also explains a very impressive target price for Vitality Biopharma shares. In short, the research outfit now believes the stock will see $2.00 per share sooner than later, based on its pipeline and potential market penetration. That’s 38% higher than its current value.

  • [By Phil Saunders]

    Vitality Biopharma, Inc. (OTCBB: VBIO) recent ascent as a strong small cap player in Cannabis pharma, is part of a boom in Cannabis-based pharmaceuticals making announcements about unique and innovative delivery systems being tested for such ailments as Epilepsy, Multiple Sclerosis, and Crohns disease. But it is important to understand how the industry is evolving in the United States and Canada and what that might mean when realizing valuation and the evolution of government policies which still vary from jurisdiction to jurisdiction, making access to Cannabis and the pricing model still a big question moving forward.

  • [By Matthew Briar]

    Back in September, Vitality Biopharma Inc (OTCMKTS:VBIO) CEO Robert Brooke officially announced his company would be entering the painkiller market, specifically taking aim at the development of an alternative to opioids. His specific words? “Opiates are one of the key classes of drugs we’re seeking to replace, or to make far less necessary, as our proprietary cannabosides could provide a potent alternative form of pain relief and help avoid, or greatly reduce, the use of opiates for the treatment of many conditions…”

Top 10 Undervalued Stocks To Own For 2019: Encore Wire Corporation(WIRE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Encore Wire (NASDAQ: WIRE) and Arconic (NYSE:ARNC) are both industrial products companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, dividends, earnings and risk.

Top 10 Undervalued Stocks To Own For 2019: Itron Inc.(ITRI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Silver Spring Networks Inc (NYSE: SSNI) got a boost, shooting up 24 percent to $16.11. Itron, Inc. (NASDAQ: ITRI) announced plans to acquire Silver Spring Networks for $16.25 per share.

Top 10 Undervalued Stocks To Own For 2019: SORL Auto Parts Inc.(SORL)

Advisors’ Opinion:

  • [By ]

    1. Sorl Auto Parts (Nasdaq: SORL)
    Shares of this Chinese automobile brake and safety equipment maker are setting up to be an ideal breakout candidate. Sorl supplies automobile brakes and safety equipment to over 75 original equipment manufacturers, most of them in China.

  • [By Lisa Levin]

    Sorl Auto Parts, Inc. (NASDAQ: SORL) was down, falling around 8 percent to $3.68. Greenridge Global downgraded SORL Auto Parts from Buy to Hold.

  • [By Lisa Levin] Gainers
    Loxo Oncology Inc (NASDAQ: LOXO) rose 32.7 percent to $65.00 in pre-market trading after the company reported that larotrectinib trial demonstrated 76 percent confirmed objective response rate.
    Dynavax Technologies Corporation (NASDAQ: DVAX) shares rose 22 percent to $7.20 in the pre-market trading session after the company on Friday presented updated data for SD-101 in combination with KEYTRUDA.
    Puma Biotechnology Inc (NASDAQ: PBYI) rose 21.7 percent to $99.75 in pre-market trading as the company disclosed positive PB272 Phase 2 data from TBCRC 022 trial at ASCO17.
    Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares rose 20.7 percent to $3.21 in pre-market trading after the company reported that RedZone has acquired all the assets of Trendit including three technology patents.
    Forestar Group Inc. (NYSE: FOR) rose 13.1 percent to $16.05 in pre-market trading after D.R. Horton, Inc. (NYSE: DHI) proposed to buy 75 percent of Forestar Group for $16.25 per share in cash.
    TG Therapeutics Inc (NASDAQ: TGTX) shares rose 12 percent to $15.50 in pre-market trading after the company said Phase 3 GENUINE trial met primary endpoint with TG-1101 + ibrutinib increasing overall response rate by >70 percent versuss ibrutinib alone.
    Gigamon Inc (NYSE: GIMO) gained 10.8 percent to $43.55. Reuters reported that Gigamon is exploring a potential sale.
    BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 8.7 percent to $6.00 in pre-market trading after the company announced Rapivab pediatric sNDA acceptance by the FDA.
    Array Biopharma Inc (NASDAQ: ARRY) rose 7.2 percent to $8.77 in pre-market trading after gaining 5.68 percent on Friday.
    Ehi Car Services Ltd (ADR) (NYSE: EHIC) shares rose 6.4 percent to $10.76 in pre-market trading. eHi Car Services posted Q1 earnings of $0.06 on sales of $89.43 million.
    Skyworks Solutions Inc (NASDAQ: SWKS) rose 5.9 percent to $114.79 in pre-market trading after gaining 0.69 percent on Friday.
    Sorl Auto
  • [By Lisa Levin]

    Sorl Auto Parts, Inc. (NASDAQ: SORL) shares shot up 19 percent to $7.15 after the company reported strong results for its third quarter and raised its FY17 outlook. The company reported Q3 EPS of 44 cents, up from 17 cents in the same quarter of last year. The company reported sales of $101.33 million, up from $63.7 million in the same quarter of last year.

  • [By Monica Gerson]

    Sorl Auto Parts, Inc. (NASDAQ: SORL) is expected to post its quarterly earnings at $0.20 per share on revenue of $55.35 million.

    Clean Diesel Technologies, Inc. (NASDAQ: CDTI) is projected to post a quarterly loss at $0.18 per share on revenue of $10.25 million.

Top 10 Undervalued Stocks To Own For 2019: Ubiquiti Networks, Inc.(UBNT)

Advisors’ Opinion:

  • [By Steve Symington]

    Shares of Ubiquiti Networks Inc.(NASDAQ:UBNT) were down 13.4% as of 1:30 p.m. EST Friday after the networking hardware company released mixed fiscal second-quarter 2017 results.

  • [By Jim Robertson]

    On Monday, small cap Ubiquiti Networks (NASDAQ: UBNT) fell 7.89%after notorious short seller Andrew Left/Citron Research issued a report calling the stock a fraud, but shares were regainingsome of what was lost in early Tuesdaytrading. Ubiquiti Networkseliminates barriers to connectivity for under-networked enterprises, communities and consumers with its leading-edge platforms that connect hundreds of millions of people throughout the world. With over 60 million devices sold worldwide, through a network of over 100 distributors, to customers in more than 180 countries and territories,the Companyhas maintained an industry-leading financial profile by leveraging a unique business model to develop products that combine innovative technology with disruptive price-to-performance characteristics.Growth is supported by the Ubiquiti Community, a global grass-roots community of 4 million entrepreneurial operators and systems integrators who engage in thousands of forums.

  • [By Lisa Levin]

    In trading on Friday, technology shares rose by just 0.2 percent. Meanwhile, top losers in the sector included Ubiquiti Networks Inc (NASDAQ: UBNT), down 14 percent, and Magnachip Semiconductor Corp (NYSE: MX), down 12 percent.

  • [By Peter Graham]

    Mid cap network communication platform makerUbiquiti Networks Inc (NASDAQ: UBNT) reportedfiscal Q4 2017 earnings before the market opened with shares surging 16.56% when the market closed. Revenues increased 23% year-over-year and 4.7% sequentially to $228.6 million, primarily driven by continued strong demand for new product offerings across the Company’s product lines. Enterprise Technology revenues increased 49% year-over-year, primarily driven by continued adoption of the Company’s UniFi product family of access points, switches, gateways and IP cameras.Service Provider Technology revenues increased 5% year-over-year and 10% sequentially, primarily driven by the Company’s airMAX AC and airMAX AC Gen 2 product lines. GAAP Net Income was $60.7 million versus $57.7 million. Total cash and cash equivalents as of June 30, 2017 were $604.2 million versus $533.9 million as of March 31, 2017, representing an increase of over 13%.

  • [By Peter Graham]

    The Q2 2017 earnings report formid cap network communication platform makerUbiquiti Networks Inc (NASDAQ: UBNT) is scheduled for after the market closes on Thursday (February 9). Ubiquiti Networkshas been in our SmallCap Network Elite Opportunity (SCN EO) portfolio as a M2M growth play with plenty of cash and very little debt. When we added the stock in November 2014, our SCN EO newsletternoted:

Hot Bank Stocks To Buy For 2019

Congress usually reserves words like “tyranny,” “destructive,” and “dangerous” for condemning intolerant regimes in the Middle East and elsewhere.

But now those same terms are being used to call for the elimination of the federal consumer protection agency that has cracked down on big banks and shady payday lenders.

Republican Rep. Jeb Hensarling penned an op-ed in The Wall Street Journal this week that denounced the “tyranny” of the Consumer Financial Protection Bureau and the “zealots” who work at the regulator.

Inspired by Senator Elizabeth Warren, the CFPB was created by the 2010 Dodd-Frank Wall Street reform law as a way to safeguard Americans from predatory lending that hurt many before the 2008 financial meltdown.

Warren recently told CNNMoney that the CFPB is doing its job of protecting “working families” from powerful financial institutions, which is precisely why big banks and the GOP “are so eager to strangle the agency.”

Wall Street hates the CFPB and Republicans says the bureau’s independence — it’s not funded by Congress and is run by a single director who doesn’t serve at the pleasure of the president — makes it a “rogue” agency.

Hot Bank Stocks To Buy For 2019: Guaranty Bancorp(GBNK)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of PATRIOT FINANCIAL PARTNERS GP, LP’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=PATRIOT+FINANCIAL+PARTNERS+GP%2C+LP

    These are the top 5 holdings of PATRIOT FINANCIAL PARTNERS GP, LPBanc of California Inc (BANC) – 2,850,564 shares, 27.82% of the total portfolio. Guaranty Bancorp (GBNK) – 1,891,767 shares, 23.36% of the total portfolio. Shares reduced by 19.22%Meta Financial Group Inc (CASH) – 347,069 shares, 14.02% of the total portfolio. Sterling Bancorp (STL) – 1,048,980 shares, 11.07% of the total portfolio. Shares reduced by 16.01%MBT Financial Corp (MBTF) – 2,060,302 sha

Hot Bank Stocks To Buy For 2019: Internap Network Services Corporation(INAP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Internap Corp (NASDAQ: INAP) got a boost, shooting up 13 percent to $2.97 on strong quarterly results. Stifel Nicolaus upgraded Internap from Hold to Buy and raised the price target from $2.00 to $5.50.

  • [By Lisa Levin]

    Shares of Internap Corp (NASDAQ: INAP) got a boost, shooting up 28 percent to $2.32 as the company reported that it has raised $43 million in a common equity private placement.

  • [By Alex McGuire]

    These are the 10 best penny stocks that have seen the biggest returns over the last week (March 7 – March 14)…

    Penny StockCurrent PriceWeekly Gain (March 7 – March 14)Ocera Therapeutics Inc. (Nasdaq: OCRX)$1.47+147.1%Internap Corp. (Nasdaq: INAP)$3.28+41.4%Soligenix Inc. (Nasdaq: SNGX)$2.94+40%Navios Maritime Partners LP (NYSE: NMM)$2.63+37%QuickLogic Corp. (Nasdaq: QUIK)$2.14+30.5%Adamis Pharmaceuticals Corp. (Nasdaq: ADMP)$4.60+22.7EXCO Resources Inc. (NYSE: XCO)$0.65+20.5%Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC)$4.38+20.3%Hebron Technology Co. Ltd. (Nasdaq: HEBT)$3.99+19.1%Curis Inc. (Nasdaq: CRIS)$2.85+18.4%

    As a reminder, this is only a tracking metric of penny stocks trading on SEC-regulated exchanges like the Nasdaq and NYSE. Although these top penny stocks are safer than those trading on the pink sheets, we don’t recommend buying any of them without the proper amount of financial research.

Hot Bank Stocks To Buy For 2019: Cherokee Inc.(CHKE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Cherokee Inc (NASDAQ: CHKE) shares dropped 37 percent to $4.85 after the company reported a loss for its first quarter on Thursday. The company reported an adjusted loss of $0.07 per share, versus analysts’ estimates for a profit of $0.13 per share.

  • [By Max Byerly]

    Cherokee (NASDAQ: CHKE) and J.Jill (NYSE:JILL) are both small-cap consumer discretionary companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

  • [By Lisa Levin]

    Cherokee Inc (NASDAQ: CHKE) shares dropped 32 percent to $5.26 after the company reported a loss for its first quarter on Thursday. The company reported an adjusted loss of $0.07 per share, versus analysts’ estimates for a profit of $0.13 per share.